|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.330 SEK | -4.18% |
|
-3.20% | -32.49% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 4/15/21 | 4/8/22 | 4/29/24 | 4/29/24 | 4/25/25 | 4/29/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 2026-06-08 | Ex-dividend date - 0.97854 SEK | 00:00 |
Upcoming Events: IRLAB Therapeutics AB
| 2026-08-26 | Earnings release | Q2 2026 | |
| 2026-11-13 | Earnings release | Q3 2026 | |
| 2027-02-11 | Earnings release | Annual 2026 | Day |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.59% | 0.65% | 34.25x | 20.52x | 12.25x | |
| 2.1% | 2.21% | 27.09x | 6.81x | 6.22x | |
| 2.81% | 2.96% | 30.33x | 4444.08x | 7.27x | |
| 3.06% | 3.14% | 17.47x | 6.47x | 4.34x | |
| 2.9% | 3% | 21.17x | 6.32x | 5.44x | |
| 2.02% | 2.13% | 20.69x | 4.85x | 4.37x | |
| 3.55% | 3.45% | 13.99x | 6.19x | 5.26x | |
| 2.84% | 3% | 23.3x | 17.92x | 6.19x | |
| 2.5% | 2.59% | -46.85x | 8.21x | 5.61x | |
| Average | 2.48% | 2.57% | 15.72x | 502.37x | 6.33x | |
| Weighted average by Cap. | 2.04% | 2.12% | 23.34x | 559.81x | 7.66x |
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
